Oliver Yoa‐Pu Hu

Taipei Tzu Chi Hospital — Taiwan

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

27h-index2.1kcitations95works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(14), Drug Transport and Resistance Mechanisms(14), Drug-Induced Hepatotoxicity and Protection(10), Pain Mechanisms and Treatments(7), Advancements in Transdermal Drug Delivery(7)

Publications95 total

Safety and Efficacy of Oral Nalbuphine on Postoperative Pain in Hemorrhoidectomy Patients
Clinical Journal of Pain·2023· 4 cited
A novel galactose electrochemical biosensor intended for point-of-care measurement of quantitative liver function using galactose single-point test
Analytical and Bioanalytical Chemistry·2022· 8 cited
Determination of Ondansetron and Metabolites in Plasma and its Pharmacokinetics in Cancer Patients
Journal of Food and Drug Analysis·2020Open Access
Development and validation of an LC-MS/MS method for simultaneous quantification of hesperidin and hesperetin in rat plasma for pharmacokinetic studies
Analytical Methods·2017· 21 cited
Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury
Archives of Toxicology·2015· 20 cited
Commonly Used Excipients Modulate UDP-Glucuronosyltransferase 2B7 Activity to Improve Nalbuphine Oral Bioavailability in Humans
Pharmaceutical Research·2014· 23 cited
Long-Term and Short-Term Effects of Hemodialysis on Liver Function Evaluated Using the Galactose Single-Point Test
The Scientific World JOURNAL·2014· 8 citedOpen Access
Genetic Polymorphisms of Metabolic Enzymes and the Pharmacokinetics of Indapamide in Taiwanese Subjects
The AAPS Journal·2013· 8 citedOpen Access
New finding of nalbuphine metabolites in men: NMR spectroscopy and UPLC–MS/MS spectrometry assays in a pilot human study
Metabolomics·2013· 16 cited
Selected Pharmaceutical Excipient Prevent Isoniazid and Rifampicin Induced Hepatotoxicity
Current Drug Metabolism·2013· 12 cited
Protective Effects of Kaempferol on Isoniazid- and Rifampicin-Induced Hepatotoxicity
The AAPS Journal·2013· 71 citedOpen Access
Simultaneous determination of nalbuphine and its prodrug sebacoly dinalbuphine ester in human plasma by ultra‐performance liquid chromatography–tandem mass spectrometry and its application to pharmacokinetic study in humans
Biomedical Chromatography·2013· 22 citedOpen Access
The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity
Pharmacogenetics and Genomics·2013· 28 cited
A Novel Mechanism Underlies the Hepatotoxicity of Pyrazinamide
Antimicrobial Agents and Chemotherapy·2013· 110 citedOpen Access
Validated liquid chromatography–tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases
Talanta·2012· 18 cited
A new approach to facilitate diagnosis of nonalcoholic fatty liver disease through a galactose single point method in rats with fatty liver
Digestive and Liver Disease·2012· 4 cited
Development of Oseltamivir Phosphonate Congeners as Anti-influenza Agents
Journal of Medicinal Chemistry·2012· 49 citedOpen Access
Herb-Drug Interaction of 50 Chinese Herbal Medicines on CYP3A4 Activity<i>in Vitro</i>and<i>in Vivo</i>
The American Journal of Chinese Medicine·2012· 60 cited
Transdermal Delivery of Nalbuphine and Nalbuphine Pivalate from Hydrogels by Passive Diffusion and Iontophoresis
Arzneimittelforschung·2011· 18 cited
Simultaneous Determination of Buprenorphine, Norbuprenorphine and Naloxone in Human Plasma by LC-MS-MS
Chromatographia·2011· 12 cited
page 1 of 5Next →

Frequent Co-authors

Li‐Heng Pao(10), K.C. Sung(8), Shung-Tai Ho(7), Cheng-Huei Hsiong(7), Pei-Wei Huang(6), Tung-Yuan Shih(4), Shung‐Tai Ho(4), Hung‐Shang Tang(3), Shiu-Pei Chang(3), Kuang-Yao Chen(3), Ning-Chi Wang(2), Jhi-Joung Wang(2), Rough-Yee Han(2), Jia-You Fang(2), Ton-Ho Young(2), Jia‐You Fang(2), Hsien‐Yuan Lane(2), Wen‐Ho Chang(2), Teh‐Min Hu(2), Chih‐Cherng Lu(2)